ERBB2 and gastric neoplasm: For a head-to-head comparison of the DAR = 8 MMAU ADC with a clinically approved ADC, Kadcyla®, we employed an in vitro 3D HER2 overexpressing gastric tumor PDX model GXA3067 (Figure 5) that more closely resembles the in vivo situation than monolayer culture [8].